NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Dow Inc. (“Dow” or the “Company”) (NYSE: DOW) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

Event featured publishers discussing the evolving media landscape and opportunities for brands to partner with news media to drive business impact WASHINGTON , Sept. 18, 2025 /PRNewswire/ -- Stagwell (NASDAQ: STGW), the challenger network built to transform marketing, convened leaders across media, marketing, and communications for its inaugural Disruptor Media Showcase in Washington, D.C.

The crude oil market fell a bit at the open on Thursday but turned things around as it looks like we are trying to reach toward the top of the overall consolidation area that we have been in for some time. At this point, the markets remain trapped in a

Markets often rally in anticipation of rate cuts but then decline when the actual rate cuts are implemented.

NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds C3.ai, Inc. (“C3” or the “Company”) (NYSE: AI) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

ENTX posts positive PK data for its first oral GLP-2 therapy, signaling a potential breakthrough in short bowel syndrome treatment.

NRG expands with LS Power deal, boosts data center strategy, and rides on a 15.8% share price surge despite fuel supply risks.

AVNS acquires Nexus Medical, adding its TKO connector to expand critical care offerings and drive immediate revenue and earnings growth.

ALC's UNITY VCS shows faster, more efficient cataract and vitreoretinal surgery results, lifting shares after study presentations.

SAN DIEGO , Sept. 18, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that a lawsuit that is currently pending for certain investors in Semtech Corporation (NASDAQ: SMTC) shares.

NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Charter Communications, Inc. (“Charter” or the “Company”) (NASDAQ: CHTR) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

Hologic (HOLX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

Its fiscal Q1 results prove its leadership position with data and cloud-based data services, and the guidance suggests the strengths will not only continue but potentially accelerate before peaking over the next few years.

NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds KinderCare Learning Companies, Inc. (“KinderCare” or the “Company”) (NYSE: KLC) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.

Novo Nordisk A/S remains a Strong Buy, driven by restructuring, pipeline advancements, and robust product developments like the Wegovy pill. NVO's restructuring will cut 9,000 jobs, saving $1.27B annually by 2026, enabling reinvestment in R&D, manufacturing, and commercial execution. Recent FDA and EMA approvals for GLP-1 drugs, plus promising obesity and diabetes treatments, position NVO for significant revenue growth by 2026.

NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Lockheed Martin Corporation (“Lockheed Martin” or the “Company”) (NYSE: LMT) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.